Regulatory factors involved in sensitivity and resistance to ferroptosis in HCC patients treated with sorafenib

Regulatory factors involved in sensitivity and resistance to ferroptosis in HCC patients treated with sorafenib. These regulatory factors mainly participate in sensitivity and resistance to ferroptosis in HCC cells treated with sorafenib through three pathways. (A) Labile iron pool: Inhibition of CISD2 promotes excessive iron accumulation through autophagy, resulting in sorafenib-induced ferroptosis in resistant cells. LIFR sensitizes HCC cells to sorafenib-induced ferroptosis through NF-κB inhibition and the subsequent downregulation of iron-sequestering LCN2. (B) The biosynthesis of PUFAs: Activation of the HBXIP/SCD axis via coactivation of ZNF263 reduces the anticancer activity of sorafenib and suppresses ferroptosis. MiR-23a-3p acts as a direct suppressor of ferroptosis by targeting the 3'UTR of ACSL4. The ETS1/miR‑23a‑3p/ACSL4 axis contributes to sorafenib resistance in HCC by regulating ferroptosis. Inhibition of the Hippo signalling pathway can activate YAP to promote the transcription of ACSL4, thereby promoting ferroptosis. The interaction mediated by E-cadherin in HepG2 cells suppresses ferroptosis by activating the intracellular NF2 and Hippo signalling pathways. (C) The defensive system against ferroptosis: In sorafenib-resistant HCC cells, YAP/TAZ and ATF4 are activated in the nucleus where they induce SLC7A11 expression. AKR1C3 suppresses ferroptosis through the regulation of YAP/SLC7A11. Binding between BECN1 and SLC7A11 increases, which inhibits the activity of System Xc- and the triggering of ferroptosis in sorafenib-treated HCC cells via the SHP-1/STAT3/MCL1 axis. C8orf76 and DAZAP1 reduce cellular sensitivity to sorafenib by acting on SLC7A11 through different mechanisms. Additionally, targeting the FASN/HIF1α/SLC7A11 pathway could resensitize HCC cells to sorafenib. S1R and macropinocytosis negatively regulate sorafenib-induced ferroptosis
Regulatory factors involved in sensitivity and resistance to ferroptosis in HCC patients treated with sorafenib

Publication

Current Progress of Ferroptosis Study in Hepatocellular Carcinoma (2024) Xinyue Zhu, et al. Int J Biol Sci. 2024;20(9). Figure: F5.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates LCN2 LCN2 ncbigene_symbol LCN2 3934
Homo sapiens Primates SHP1 SHP1 ncbigene_synonym PTPN6 5777
Homo sapiens Primates SHP1 SHP1 ncbigene_synonym NR0B2 8431
Homo sapiens Primates CISD2 CISD2 ncbigene_symbol CISD2 493856
Homo sapiens Primates LIP LIP ncbigene_synonym SMG1 23049
Homo sapiens Primates LIFR LIFR ncbigene_symbol LIFR 3977
Homo sapiens Primates STAT3 STAT3 ncbigene_symbol STAT3 6774
Homo sapiens Primates SLC3A2 SLC3A2 ncbigene_symbol SLC3A2 6520
Homo sapiens Primates SLC7A11 SLC7A11 ncbigene_symbol SLC7A11 23657
Homo sapiens Primates BECN1 BECN1 ncbigene_symbol BECN1 8678
Homo sapiens Primates NF-kB NF-KB ncbigene_synonym NFKB1 4790
Homo sapiens Primates MCL1 MCL1 ncbigene_symbol MCL1 4170
Homo sapiens Primates ZNF263 ZNF263 ncbigene_symbol ZNF263 10127
Homo sapiens Primates HBXIP HBXIP ncbigene_synonym LAMTOR5 10542
Homo sapiens Primates EST1 EST1 ncbigene_synonym SULT1E1 6783
Homo sapiens Primates C8orf76 C8ORF76 ncbigene_symbol C8orf76 84933
Homo sapiens Primates DAZAP1 DAZAP1 ncbigene_symbol DAZAP1 26528
Homo sapiens Primates GPX4 GPX4 ncbigene_symbol GPX4 2879
Homo sapiens Primates S1R S1R ncbigene_synonym TMBIM4 51643
Homo sapiens Primates HIF-1a HIF-1A ncbigene_synonym HIF1A 3091
Homo sapiens Primates FASN FASN ncbigene_symbol FASN 2194
Homo sapiens Primates AKR1C3 AKR1C3 ncbigene_symbol AKR1C3 8644
Homo sapiens Primates YAP YAP ncbigene_synonym YAP1 10413
Homo sapiens Primates TAZ TAZ ncbigene_synonym TAFAZZIN 6901
Homo sapiens Primates TAZ TAZ ncbigene_synonym WWTR1 25937
Homo sapiens Primates ATF4 ATF4 ncbigene_symbol ATF4 468
Homo sapiens Primates TEAD TEAD famplex_relations TEAD1 7003
Homo sapiens Primates TEAD TEAD famplex_relations TEAD2 8463
Homo sapiens Primates TEAD TEAD famplex_relations TEAD3 7005
Homo sapiens Primates TEAD TEAD famplex_relations TEAD4 7004
Homo sapiens Primates ACSL4 ACSL4 ncbigene_symbol ACSL4 2182
Homo sapiens Primates NF2 NF2 ncbigene_symbol NF2 4771
Homo sapiens Primates SCD SCD ncbigene_symbol SCD 6319
Homo sapiens Primates SCD SCD famplex_relations SCD5 79966
Homo sapiens Primates PUFA PUFA ncbigene_synonym PUM3 9933
Homo sapiens Primates E-cadherin CDH1 ncbigene_symbol CDH1 999
Homo sapiens Primates E-cadherin CDH1 ncbigene_synonym FZR1 51343

Chemical mentions

Word Match MeSH Name ChEBI
Fe3+ Fe3+ iron(3+) ion chebi:29034
Fe2+ Fe2+ iron(2+) chebi:29033
Lipid Lipid lipids chebi:18059
MUFA MUFA chebi:25413
Sorafenib sorafenib 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide chebi:50924
GSH GSH L-gamma-glutamyl-L-cysteinylglycine chebi:16856
Nucleus nucleus nucleus chebi:33252
Sorafenib sorafenib 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide chebi:50924
Lipid Lipid lipids chebi:18059
Lipid Lipid lipids chebi:18059
PUFA PUFA chebi:76567

Disease mentions

Word Match MeSH Name DOID